OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexins and fear: implications for the treatment of anxiety disorders
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Inhibition in the amygdala anxiety circuitry
Olga Babaev, Carolina Piletti Chatain, Dilja Krueger‐Burg
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 4, pp. 1-16
Open Access | Times Cited: 256

Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour
Patricia Bonnavion, Laura E. Mickelsen, Akie Fujita, et al.
The Journal of Physiology (2016) Vol. 594, Iss. 22, pp. 6443-6462
Open Access | Times Cited: 220

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205

The Brainstem in Emotion: A Review
Anand Venkatraman, Brian L. Edlow, Mary Helen Immordino‐Yang
Frontiers in Neuroanatomy (2017) Vol. 11
Open Access | Times Cited: 195

The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Gerard Sanacora, Zhen Yan, Maurizio Popoli
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 86-103
Closed Access | Times Cited: 125

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22

Orexins and stress
Laura A. Grafe, Seema Bhatnagar
Frontiers in Neuroendocrinology (2018) Vol. 51, pp. 132-145
Open Access | Times Cited: 106

Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102

Sleep in posttraumatic stress disorder: A systematic review and meta-analysis of polysomnographic findings
Ye Zhang, Rong Ren, Larry D. Sanford, et al.
Sleep Medicine Reviews (2019) Vol. 48, pp. 101210-101210
Closed Access | Times Cited: 100

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77

The hypothalamus as a primary coordinator of memory updating
Denis Burdakov, Daria Peleg‐Raibstein
Physiology & Behavior (2020) Vol. 223, pp. 112988-112988
Open Access | Times Cited: 62

Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Harry Fagan, David S. Baldwin
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 6, pp. 535-548
Open Access | Times Cited: 21

Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19

On making (and turning adaptive to) maladaptive aversive memories in laboratory rodents
Lucas Gazarini, Cristina Aparecida Jark Stern, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2023) Vol. 147, pp. 105101-105101
Closed Access | Times Cited: 17

The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa
Artur Pałasz, Małgorzata Janas–Kozik, Amanda P. Borrow, et al.
Neurochemistry International (2017) Vol. 113, pp. 120-136
Open Access | Times Cited: 50

Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40

Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior
Jazmine D. W. Yaeger, Kevin T. Krupp, Benjamin Jacobs, et al.
Biological Psychiatry (2022) Vol. 91, Iss. 9, pp. 841-852
Open Access | Times Cited: 22

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13

Functional Anatomy of the Structures of the Limbic System Involved in the Development of Neuropsychiatric Disorders: A Review
Nataliya Zharova, Artem S. Osadchiy, Anastasia Lobanova, et al.
Current Behavioral Neuroscience Reports (2025) Vol. 12, Iss. 1
Closed Access

Analysis of Anxiety Disorders and Post-Traumatic Stress Disorders for Screening Anxiolytic Drugs and Linking Preclinical and Clinical Research
Anna Kozłowska, Wan-Jiun Ma, Bai‐Chuang Shyu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1414-1414
Open Access

Preclinical Behavioral and Pharmacological Treatments for Enhancing Fear Extinction in Adolescence
Emily K. Wall, Elizabeth A Virakorn, Kathryn Baker, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106090-106090
Open Access

Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock T. Shireman, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top